Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Abstract: Small-molecule inhibitor of apoptosis (IAP) antagonists, called Smac mimetic compounds (SMCs), sensitize tumours to TNF-α-induced killing while simultaneously blocking TNF-α growth-promoting activities. SMCs also regulate several immunomodulatory properties within immune cells. We report that SMCs synergize with innate immune stimulants and immune checkpoint inhibitor biologics to produce durable cures in mouse models of glioblastoma in which single agent therapy is ineffective. The complementation of activities between these classes of therapeutics is dependent on cytotoxic T-cell activity and is associated with a reduction in immunosuppressive T-cells. Notably, the synergistic effect is dependent on type I IFN and TNF-α signalling. Furthermore, our results implicate an important role for TNF-α-producing cytotoxic T-cells in mediating the anti-cancer effects of immune checkpoint inhibitors when combined with SMCs. Overall, this combinatorial approach could be highly effective in clinical application as it allows for cooperative and complimentary mechanisms in the immune cell-mediated death of cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Nature Communications. - 8 (2017) , ISSN: 2041-1723
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
-
Beug, Shawn T.
Beauregard, Caroline E.
Healy, Cristin
Sanda, Tarun
St-Jean, Martine
Chabot, Janelle
Walker, Danielle E.
Mohan, Aditya
Earl, Nathalie
Lun, Xueqing
Senger, Donna L.
Robbins, Stephen M.
Stäheli, Peter
Forsyth, Peter A.
Alain, Tommy
LaCasse, Eric C.
Korneluk, Robert G.
- DOI
-
10.1038/ncomms14278
- URN
-
urn:nbn:de:bsz:25-freidok-1369642
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Beug, Shawn T.
- Beauregard, Caroline E.
- Healy, Cristin
- Sanda, Tarun
- St-Jean, Martine
- Chabot, Janelle
- Walker, Danielle E.
- Mohan, Aditya
- Earl, Nathalie
- Lun, Xueqing
- Senger, Donna L.
- Robbins, Stephen M.
- Stäheli, Peter
- Forsyth, Peter A.
- Alain, Tommy
- LaCasse, Eric C.
- Korneluk, Robert G.
- Universität
Entstanden
- 2019
Ähnliche Objekte (12)
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment
Evaluation of the pleiotropic effects of Smac mimetic on glioblastoma cells
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
Proceedings of SMAC 2013
Evaluation of the bivalent Smac mimetic BV6 and Interferon α as a combination treatment in Glioblastoma multiforme
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity
Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis
Targeted mutation of the tumour suppressor gene CYLD reveals a novel role in adaptive immunity
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment
Evaluation of the pleiotropic effects of Smac mimetic on glioblastoma cells
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
Proceedings of SMAC 2013
Evaluation of the bivalent Smac mimetic BV6 and Interferon α as a combination treatment in Glioblastoma multiforme
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity
Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis
Targeted mutation of the tumour suppressor gene CYLD reveals a novel role in adaptive immunity
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment
Evaluation of the pleiotropic effects of Smac mimetic on glioblastoma cells
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
Proceedings of SMAC 2013
Evaluation of the bivalent Smac mimetic BV6 and Interferon α as a combination treatment in Glioblastoma multiforme
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity
Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis